| Autor: |
Tang, Chaojie, Shen, Yihong, Xing, Yazhi, Wu, Yufan, Zhang, Mianmian, Zhang, He, Zhao, Shuo, Zhou, Zhiguo, Sun, Yongning, Mo, Xiumei, Wang, Wu |
| Zdroj: |
ACS Biomaterials Science & Engineering; October 2024, Vol. 10 Issue: 10 p6483-6497, 15p |
| Abstrakt: |
Endovascular treatment (EVT) using stents has become the primary option for severe cerebrovascular stenosis. However, considerable challenges remain to be addressed, such as in-stent restenosis (ISR) and late thrombosis. Many modified stents have been developed to inhibit the hyperproliferation of vascular smooth muscle cells (SMCs) and protect vascular endothelial cells (VECs), thereby reducing such complications. Some modified stents, such as those infused with rapamycin, have improved in preventing acute thrombosis. However, ISR and late thrombosis, which are long-term complications, remain unavoidable. Panax notoginsengsaponin(PNS), a traditional Chinese medicine consisting of various compounds, is beneficial in promoting the proliferation and migration of VECs and inhibiting the proliferation of SMCs. Herein, a 3D-printed polycaprolactone (PCL) stent loaded with PNS (PNS–PCL stent) was developed based on a previous study. In vitrostudies confirmed that PNS promotes the migration and proliferation of VECs, which were damaged, by increasing the expression levels of microRNA-126, p-AKT, and endothelial nitric oxide synthase. In vivo, the PNS–PCL stents maintained the patency of the carotid artery in rabbits for up to three months, outperforming the PCL stents. The PNS–PCL stents may present a new solution for the EVT of cerebrovascular atherosclerotic stenosis in the future. |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
